SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 20th, 2003 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 10, 2003, among OXiGENE, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”); and
STOCK PURCHASE WARRANT To Purchase 187,500 Shares of Common Stock of OXiGENE, Inc.Security Agreement • June 20th, 2003 • Oxigene Inc • Biological products, (no disgnostic substances)
THIS STOCK PURCHASE WARRANT CERTIFIES that, for value received, Riverview Group, LLC (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 10, 2003 (the “Initial Exercise Date”) and on or prior to the close of business on June 9, 2005 (the “Termination Date”) but not thereafter, to subscribe for and purchase from OXiGENE, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to 187,500 shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $15.00, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 20th, 2003 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 10, 2003, by and among OXiGENE, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
